Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...